SEARCH

SEARCH BY CITATION

References

  • 1
    Dec, G. W. and Fuster, V., Idiopathic dilated cardiomyopathy. N. Engl. J. Med. 1994. 331: 15641575.
  • 2
    Richardson, P., McKenna, W., Bristow, M., Maisch, B., Mautner, B., O'Connell, J., Olsen, E. et al., Report of the WHO/ISFC task force on the definition and classification of cardiomyopathies. Circulation 1996. 93: 841842.
  • 3
    Felker, G. M., Thompson, R. E., Hare, J. M., Hruban, R. H., Clemetson, D. E., Howard, D. L., Baughman, K. L. et al ., Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N. Engl. J. Med. 2000. 342: 10771084.
  • 4
    Fallon, J. T., Myocarditis and dilated cardiomyopathy: different stages of the same disease? Cardiovasc. Clin. 1988. 18: 155162.
  • 5
    Lange, L. G. and Schreiner, G. F., Immune mechanisms of cardiac disease. N. Engl. J. Med. 1994. 330: 11291135.
  • 6
    Kawai, C., From myocarditis to cardiomyopathy: mechanisms of inflammation and cell death: learning from the past for the future. Circulation 1999. 99: 10911100.
  • 7
    Hjalmarson, A., Fu, M. and Mobini, R., Who are the enemies? Inflammation and autoimmune mechanisms. Eur. Heart J. 2002. 4(Suppl G): G27G32.
  • 8
    Pauschinger, M., Bowles, N. E., Fuentes-Garcia, F. J., Pham, V., Kuhl, U., Schwimmbeck, P. L., Schultheiss, H. P. et al., Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 1999. 99: 13481354.
  • 9
    Bowles, N. E., Ni, J., Kearney, D. L., Pauschinger, M., Schultheiss, H. P., McCarthy, R., Hare, J. et al., Detection of viruses in myocardial tissues by polymerase chain reaction: evidence of adenovirus as a common cause of myocarditis in children and adults. J. Am. Coll. Cardiol. 2003. 42: 466472.
  • 10
    Caforio, A. L., Grazzini, M., Mann, J. M., Keeling, P. J., Bottazzo, G. F., McKenna, W. J. and Schiaffino, S., Identification of α- and β-cardiac myosin heavy chain isoforms as major autoantigens in dilated cardiomyopathy. Circulation 1992. 85: 17341742.
  • 11
    Fu, L.X., Magnusson, Y., Bergh, C. H., Liljeqvist, J. A., Waagstein, F., Hjalmarson, A. and Hoebeke, J., Localization of a functional autoimmune epitope on the muscarinic acetylcholine receptor-2 in patients with idiopathic dilated cardiomyopathy. J. Clin. Invest. 1993. 91: 19641968.
  • 12
    Wang, Z. H., Liao, Y. H. and Fu, M., The frequency of occurrence of autoantibodies against β1-adrenoceptors and its clinical relevance in patients with hepatitis virus myocarditis. Autoimmunity 2001. 34: 241245.
  • 13
    Takata, S., Nakamura, H., Umemoto, S., Yamaguchi, K., Sekine, T., Kato, T., Nishioka, K. et al., Identification of autoantibodies with the corresponding antigen for repetitive coxsackievirus infection-induced cardiomyopathy. Circ. J. 2004. 68: 677682.
  • 14
    Nussinovitch, U. and Shoenfeld, Y., The diagnostic and clinical significance of anti-muscarinic receptor autoantibodies. Clin. Rev. Allergy. Immunol. 2011. In press.
  • 15
    Smith, S. C. and Allen, P. M., Myosin-induced acute myocarditis is a T cell-mediated disease. J. Immunol. 1991. 147: 21412147.
  • 16
    Iwata, M., Yoshikawa, T., Baba, A., Anzai, T., Nakamura, I., Wainai, Y., Takahashi, T. et al., Autoimmunity against the second extracellular loop of β(1)-adrenergic receptors induces β-adrenergic receptor desensitization and myocardial hypertrophy in vivo. Circ. Res. 2001. 88: 578586.
  • 17
    Jahns, R., Boivin, V., Hein, L., Triebel, S., Angermann, C. E., Ertl, G. and Lohse, M. J., Direct evidence for a β1-adrenergic receptor-directed autoimmune attack as a cause of idiopathic dilated cardiomyopathy. J. Clin. Invest. 2004. 113: 14191429.
  • 18
    Li, Y., Heuser, J. S., Cunningham, L. C., Kosanke, S. D. and Cunningham, M. W., Mimicry and antibody-mediated cell signaling in autoimmune myocarditis. J Immunol. 2006. 177: 82348240.
  • 19
    Mascaro-Blanco, A., Alvarez, K., Yu, X., Lindenfeld, J., Olansky, L., Lyons, T., Duvall, D. et al., Consequences of unlocking the cardiac myosin molecule in human myocarditis and cardiomyopathies. Autoimmunity 2008. 41: 442453.
  • 20
    Amagai, M., Tsunoda, K., Suzuki, H., Nishifuji, K., Koyasu, S. and Nishikawa, T., Use of autoantigen-knockout mice in developing an active autoimmune disease model for pemphigus. J. Clin. Invest. 2000. 105: 625631.
  • 21
    Hoch, W., McConville, J., Helms, S., Newsom-Davis, J., Melms, A. and Vincent, A., Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med. 2001. 7: 365368.
  • 22
    Jane-wit, D., Altuntas, C. Z., Johnson, J. M., Yong, S., Wickley, P. J., Clark, P., Wang, Q. et al., β1-adrenergic receptor autoantibodies mediate dilated vardiomyopathy by agonistically inducing cardiomyocyte apoptosis. Circulation 2007. 116: 399410.
  • 23
    Watanabe, E., Yasui, K., Kamiya, K., Yamaguchi, T., Sakuma, I., Honjo, H., Ozaki, Y. et al., Upregulation of KCNE1 induces QT interval prolongation in patients with chronic heart failure. Circ. J. 2007. 71: 471478.
  • 24
    Dörffel, W. V., Felix, S. B., Wallukat, G., Brehme, S., Bestvater, K., Hofmann, T., Kleber, F. X. et al., Short-term hemodynamic effects of immunoadsorption in dilated cardiomyopathy. Circulation 1997. 95: 19941997.
  • 25
    Felix, S. B., Staudt, A., Dörffel, W. V., Stangl, V., Merkel, K., Pohl, M., Döcke, W.D. et al., Hemodynamic effects of immunoadsorption and subsequent immunoglobulin substitution in dilated cardiomyopathy: three-month results from a randomized study. J. Am. Coll. Cardiol. 2000. 35: 15901598.
  • 26
    Felix, S. B., Staudt, A., Landsberger, M., Grosse, Y., Stangl, V., Spielhagen, T., Wallukat, G. et al., Removal of cardiodepressant antibodies in dilated cardiomyopathy by immunoadsorption. J. Am. Coll. Cardiol. 2002. 39: 646652.
  • 27
    Del Corsso, C., de Carvalho, A. C., Martino, H. F. and Varanda, W. A., Sera from patients with idiopathic dilated cardiomyopathy decrease ICa in cardiomyocytes isolated from rabbits. Am. J. Physiol. Heart Circ. Physiol. 2004. 287: H19281936.
  • 28
    Müller, J., Wallukat, G., Dandel, M., Bieda, H., Brandes, K., Spiegelsberger, S., Nissen, E. et al., Immunoglobulin adsorption in patients with idiopathic dilated cardiomyopathy. Circulation 2000. 101: 385391.
  • 29
    Baba, A., Akaishi, M., Shimada, M., Monkawa, T., Wakabayashi, Y., Takahashi, M., Nagatomo, Y. et al., Complete elimination of cardiodepressant IgG3 autoantibodies by immunoadsorption in patients with severe heart failure. Circ J. 2010. 74: 13721378.
  • 30
    Krejci, A. and Tucek, S., Quantitation of mRNAs for M(1) to M(5) subtypes of muscarinic receptors in rat heart and brain cortex. Mol. Pharmacol. 2002. 61: 12671272.
  • 31
    Staudt, A., Schäper, F., Stangl, V., Plagemann, A., Böhm, M., Merkel, K., Wallukat, G. et al., Immunohistological changes in dilated cardiomyopathy induced by immunoadsorption therapy and subsequent immunoglobulin substitution. Circulation 2001. 103: 26812686.
  • 32
    Staudt, A., Böhm, M., Knebel, F., Grosse, Y., Bischoff, C., Hummel, A., Dahm, J. B. et al., Potential role of autoantibodies belonging to the immunoglobulin G-3 subclass in cardiac dysfunction among patients with dilated cardiomyopathy. Circulation 2002. 106: 24482453.
  • 33
    Marleau, A. M. and Sarvetnick, N., T-cell homeostasis in tolerance and immunity. J. Leukoc. Biol. 2005. 278: 575584.
  • 34
    Krupica, T. Jr., Fry, T. J. and Mackall, C. L., Autoimmunity during lymphopenia: a two-hit model. Clin. Immunol. 2006. 120: 121128.
  • 35
    Zhao, R., Wang, W., Wu, B., Hoebeke, J., Hjalmarson, A. and Fu, M. L., Effects of anti-peptide antibodies against the second extracellular loop of human M2 muscarinic acetylcholine receptors on transmembrane potentials and currents in guinea pig ventricular myocytes. Mol. Cell Biochem. 1996. 163–164: 185193.
  • 36
    Li, D., Melnyk, P., Feng, J., Wang, Z., Petrecca, K., Shrier, A. and Nattel, S., Effects of experimental heart failure on atrial cellular and ionic electrophysiology. Circulation 2000. 101: 26312638.
  • 37
    Chiale, P. A., Ferrari, I., Mahler, E., Vallazza, M. A., Elizari, M. V., Rosenbaum, M. B. and Levin, M. J., Differential profile and biochemical effects of antiautonomic membrane receptor antibodies in ventricular arrhythmias and sinus node dysfunction. Circulation 2001. 103: 17651771.
  • 38
    Baba, A., Yoshikawa, T., Fukuda, Y., Sugiyama, T., Shimada, M., Akaishi, M., Tsuchimoto, K. et al., Autoantibodies against M2-muscarinic acetylcholine receptors: new upstream targets in atrial fibrillation in patients with dilated cardiomyopathy. Eur. Heart J. 2004. 25: 11081115.
  • 39
    Stavrakis, S., Yu, X., Patterson, E., Huang, S., Hamlett, S. R., Chalmers, L., Pappy, R. et al., Activating autoantibodies to the beta-1 adrenergic and m2 muscarinic receptors facilitate atrial fibrillation in patients with Graves’ hyperthyroidism. J. Am. Coll. Cardiol. 2009. 54: 13091316.
  • 40
    Matsui, M., Motomura, D., Fujikawa, T., Jiang, J., Takahashi, S., Manabe, T. and Taketo, M., Mice lacking M2 and M3 muscarinic acetylcholine receptors are devoid of cholinergic smooth muscle contractions but still viable. J. Neurosci. 2002. 22: 1062710632.
  • 41
    Yan, F., John, S. K., Wilson, G., Jones, D. S., Washington, M. K. and Polk, D. B., Kinase suppressor of Ras-1 protects intestinal epithelium from cytokine-mediated apoptosis during inflammation. J. Clin. Invest. 2004. 114: 12721280.
  • 42
    Camussi, G., Tetta, C., Deregibus, M. C., Bussolino, F., Segoloni, G. and Vercellone, A., Platelet-activating factor (PAF) in experimentally induced rabbit acute serum sickness: role of basophil-derived PAF in immune complex deposition. J. Immunol. 1982. 128: 8694.
  • 43
    Zaba, L. C., Cardinale, I., Gilleaudeau, P., Sullivan-Whalen, M., Suárez-Fariñas, M., Fuentes-Duculan, J., Novitskaya, I. et al., Amelioration of epidermal hyperplasia by TNF inhibition is associated with reduced Th17 responses. J. Exp. Med. 2007. 204: 31833194.
  • 44
    Kodama, H., Fukuda, K., Pan, J., Makino, S., Baba, A., Hori, S. and Ogawa. S., Leukemia inhibitory factor, a potent cardiac hypertrophic cytokine, activates the JAK/STAT pathway in rat cardiomyocytes. Circ. Res. 1997. 81: 656663.
  • 45
    Murata, M., Fukuda, K., Ishida, H., Miyoshi, S., Koura, T., Kodama, H., Nakazawa, H. K. et al., Leukemia inhibitory factor, a potent cardiac hypertrophic cytokine, enhances L-type Ca2+ current and [Ca2+]i transient in cardiomyocytes. J. Mol. Cell. Cardiol. 1999. 31: 237245.
  • 46
    Pönicke, K., Heinroth-Hoffmann, I. and Brodde, O., Demonstration of functional M3-muscarinic receptors in ventricular cardiomyocytes of adult rats. Br. J. Pharmacol. 2003. 138: 156160.
  • 47
    Hagiwara, Y., Miyoshi, S., Fukuda, K., Nishiyama, N., Ikegami, Y., Tanimoto, K., Murata, M. et al., SHP2-mediated signaling cascade through gp130 is essential for LIF-dependent I CaL,[Ca2+]i transient, and APD increase in cardiomyocytes. J. Mol. Cell. Cardiol. 2007. 43: 710716.
  • 48
    Tanaka, H., Sekine, T., Nishimaru, K. and Shigenobu, K., Role of sarcoplasmic reticulum in myocardial contraction of neonatal and adult mice. Comp. Biochem. Physiol. A Mol. Integr. Physiol. 1998. 120: 431438.